MEMansour Esmailidehaj

Mansour Esmailidehaj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mansour Esmailidehaj has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • MG53 as a Potential Therapeutic Target for Myocardial Infarction Injury

    by Zeinab Farhadi, Mansour Esmailidehaj, Fatemeh Zare Mehrjardi, Hossein Azizian

    Introduction: Myocardial infarction (MI) leads to irreversible cardiomyocyte loss and progressive ventricular remodeling largely driven by oxidative stress, inflammation, and mitochondrial dysfunction. Mitsugumin 53 (MG53/TRIM72) is a muscle-enriched membrane-repair protein that has emerged as a multifunctional regulator of cellular antioxidant responses, mitochondrial integrity, and anti-inflammatory signaling. This review synthesizes current evidence on the MG53’s mechanisms and therapeutic potential in MI. Methods: We performed a narrative review of preclinical and translational literature focusing on MG53 in cardiac injury. Databases searched included PubMed and Google Scholar (through 2025), using keywords "MG53," "TRIM72," "myocardial infarction," "isch-emia-reperfusion," "recombinant MG53," and "cardioprotection." Relevant mechanistic studies, recombinant protein interventions, and reports on the MG53’s systemic effects and safety were prioritized. Results: Preclinical studies demonstrate that MG53 promotes plasma-membrane resealing, preserves mitochondrial membrane potential, reduces mitochondrial ROS production, attenuates mitophagy, and upregulates endogenous antioxidant enzymes (e.g., HO-1, catalase, SOD). Recombinant human MG53 (rhMG53) or MG53 overexpression reduces infarct size, limits cardiomyocyte apoptosis, and improves functional recovery in rodent ischemia–reperfusion models. Additional benefits include suppression of NF-κB–mediated inflammation and modulation of necroptotic pathways via RIPK1 ubiquitination. However, there are conflicting data: chronic MG53 upregulation in some models has been associated with insulin signaling perturbation, and human data remain limited with variable reports on the cardiac MG53 expression and circulating levels. Safety, pharmacokinetics, and optimal delivery strategies for rhMG53 require further characterization. Conclusion: MG53 represents a promising cardioprotective target for MI through multimodal actions on membrane repair, mitochondrial protection, and antioxidant gene regulation. Translation to clinical therapy will require rigorous preclinical safety profiling, clarification of MG53’s systemic metabolic effects, and well-designed early-phase studies to evaluate pharmacology, dosing, and efficacy in humans. Future studies should explicitly address human expression patterns and reconcile metabolic concerns to safely harness MG53-based in-terventions.

  • A Comprehensive Review of the Pharmacological Effects of Genus Ferula on Central Nervous System Disorders

    by Seyyed Majid Bagheri, Mansour Esmailidehaj

    Background: Plants of the genus Ferula have long been used to treat neurological diseases such as Alzheimer's disease (AD), pain, depression, and seizures. The main compounds include coumarins, monoterpenes, sulfide compounds, and polyphenol compounds, which can improve the functioning of the nervous system. Objective: This article has been compiled with the aim of collecting evidence and articles related to the Ferula effects on central nervous system disease. Methods: This review article was prepared by searching the terms Ferula and analgesic, anticonvulsant, antidepressant, anti-multiple sclerosis, anti-dementia, and neuroprotective effects.The relevant information was collected through searching electronic databases such as ISI Web of Knowledge, PubMed, and Google Scholar. Results: Genus Ferula has a protective effect on nerve cells by reducing cytokines such as IL-6, IL- 1b, and TNF-α. Therefore, the effects of Ferula plants and their effective ingredients can be used to prevent or improve diseases that destroy the nervous system. The members of this genus play a role in strengthening and improving the antioxidant system, reducing the level of oxidative stress, and inhibiting or reducing inflammatory factors in the nervous system. Conclusion: Although the effects of several species of Ferula on the nervous system have been investigated, most studies have not clearly identified the molecular mechanisms as well as the specific functional regions of the brain. The present study was compiled in order to investigate different aspects of the effects of Ferula plants on the central nervous system.


  • Open Access

    Enriched-asafoetida diet attenuates hyperglycemia, oxidative stress and endothelial dysfunction in type 2 diabetic rats

    by Mansour Esmailidehaj, Mahboobe Kahtenaroon, Mohammad Ebrahim Rezvani, Hossein Azizian, Alimohammad Ranjbar

    Introduction: It has been documented that oxidative stress and inflammation are the main causes of diabetic-induced disorders. Several studies have been reported the antioxidant and antidiabetic effects of prepared asafoetida extracts, from Ferula assa-foetida L. species in the Apiaceae family. The aim of the present study was to evaluate the ...


    • 1 July 2020
      • Vol. 10  (4) , 407-416
    Open Access

    Role of the potassium channels in vasorelaxant effect of asafoetida essential oil

    by Hassan Esmaeili, Mansour Esmailidehaj, Somayeh Entezari Zarch, Hossein Azizian

    Objective: In a previous work, we showed that asafoetida essential oil (AEO), from oleo-gum resin of Ferula asafoetida L. from the Apiaceae family, has a vasodilatory effect. This effect was both endothelium-dependent and endothelium-independent. The present study was designed to determine whether potassium channels and intracellular calcium release contribute to AEO-induced vasodilation. Materials and Methods: Rats' thoracic aorta were isolated and denuded. Following induction of contraction by potassium chloride (60 mM), concentration-response curve was plotted by the cumulative addition of AEO (0.625-80 mu l/l to the medium of rings. The vasodilatory effect of AEO was assessed before and after addition of phenylephrine and potassium channel blockers (including barium chloride (BC), 4-aminopyridine (4A) and glibenclamide (Gl)). Results: AEO relaxed the precontracted rings in a concentration-dependent manner (IC50=23 mu l/l). All potassium channel blockers significantly attenuated the vasodilatory activity of AEO when they were added to rings medium before addition of KCl (p<0.01, 4A and Gl groups and p<0.001, BC group vs. control group) but not after that. In contrast to K channel blockers, adding AEO before or after phenylephrine, the tension was reduced significantly (p<0.05 vs. the control group). Conclusion: The findings of this study indicated that the vasodilatory effect of AEO on denuded-endothelium aortic ring was mediated through activation of potassium channels and reduced intracellular calcium release.


  • Open Access

    Effect of oleuropein on myocardial dysfunction and oxidative stress induced by ischemic-reperfusion injury in isolated rat heart

    by Mansour Esmailidehaj, Shirin Bajoovand, Mohammad Ebrahim Rezvani, Mozhdeh Sherifidehaj, Zahra Hafezimoghadam, Zeynab Hafizibarjin


  • Open Access

    The Effect of Atorvastatin on Preventing Noise-Induced Hearing Loss: An Experimental Study

    by L Jahani, Ah Mehrparvar, M Esmailidehaj, Me Rezvani, B Moghbeolohossein, Z Razmjooei

    The Effect of Atorvastatin on Preventing Noise-Induced Hearing Loss: An Experimental Study


  • Open Access

    Prophylactic and Therapeutic Effects of Oleuropein on Reperfusion-Induced Arrhythmia in Anesthetized Rat

    by Babak Baharvand, Mansour Esmailidehaj, Jamileh Alihosaini, Shirin Bajoovand, Saeedeh Esmailidehaj, Zeynab Hafizi Barjin

    This study was conducted to reveal that whether i.v. injection of oleuropein, the most potent polyphenolic antioxidant in olive leaf, has any effect on the magnitude of reperfusion arrhythmia in anesthetized rats or not. Eighty male Wistar rats were divided into 8 groups of 10 each: groups 1 and 5 were assigned as the prophylactic and treatment control groups, groups 2 and 6 as the prophylactic and treatment groups with lidocaine (10 mg/kg), groups 3 and 4 as the prophylactic groups with 10 and 50 mg/kg oleuropein (i.v.), and groups 7 and 8 as the treatment groups with 10 and 50 mg/kg oleuropein (i.v.), respectively. Reperfusion injury was induced by 5-min regional ischemia and 15-min reperfusion of left anterior descending coronary artery. Heart rate, blood pressure, and electrocardiogram were monitored throughout the procedure. blood pressure was significantly decreased by infusion of 50 mg/kg oleuropein in groups 4 and 8, but unlike the lidocaine as a standard anti-arrhythmic drug in groups 2 and 5 had not significant effect on heart rate. The onset of arrhythmia in groups received oleuropein (groups 3, 4, 7, and 8) was significantly delayed. The mortality rate due to irreversible ventricular fibrillation was also significantly reduced in groups 3, 4, 7, and 8. The effect of lidocaine in groups 2 and 5 was more potent than that in oleuropein group. These findings indicate that i.v. injection of oleuropein possibly through its antioxidant activity reduces the magnitude of reperfusion-induced arrhythmia.


  • Hyperoxia-induced preconditioning against renal ischemic injury is mediated by reactive oxygen species but not related to heat shock proteins 70 and 32

    by Hannaneh Wahhabaghai, Reza Heidari, Atefeh Zeinoddini, Saeed Soleyman-Jahi, Leila Golmanesh, Bahram Rasoulian, Hassan Akbari, Mohsen Foadoddoni, Mansour Esmailidehaj


  • Open Access

    Pretreatment with Assafoetida exerts dose-dependent dual effects on rat hearts

    by MohammadHossein Mosaddeghmehrjardi, Mansour Esmailidehaj, Mohadeseh Kakoo, MohammadEbrahim Rezvani, Rezvani Me

    Context: Although many studies displayed the favorable effects of Assafoetida, some of them reported that high doses of Assafoetida could lead to harmful effects. Aims: In this study, the effect of pretreatment with Assafoetida investigated on ischemic-reperfusion injury in isolated rat heart model. Materials and Methods: Thirty two male Wistar rats were divided into 4 groups of eight. Group 1 as the control (Con) group and three other groups as the treatment groups that given Assafoetida by gavage at levels of 25, 50 and 100 mg/kg, once a day for four weeks (T25, T50 and T100 groups). Then their hearts were subjected to 30 min global ischemia and 90 min reperfusion under langendorff apparatus. Results: The data shown that hemodynamic parameters including left ventricular developed pressure (LVDP) and maximum and minimum of pressure changes (±dp/dt) were increased in T25 and decreased in T50 and T100 groups during reperfusion in comparison with Con group. There was not any significant difference in the incidence of irreversible ventricular fibrillation between T25 and Con group, while it was increased in T50 and T100 groups significantly. There was not any significant difference in infarct size between all groups. Conclusion: These data indicate that pretreatment of rats with Assafoetida have cardioprotective effects in low doses and cardiotoxic effects in higher doses. Therefore, it needs more investigation in the future.


    • 1 January 2012
      • Vol. 11  (4) , 1255-63
    Open Access

    Prolonged Oral Administration of Oleuropein Might Protect Heart against Aconitine-induced Arrhythmia.

    by Mansour Esmailidehaj, Seyed-Jalil Mirhosseini, Mohammad Ebrahim Rezvani, Bahram Rasoulian, Mohammad Hossein Mosaddeghmehrjardi, Damoon Haghshenas

    In this study, it was surveyed to know whether an oral single dose of oleuropein could mimic the cardiac preconditioning in rats' hearts or whether its prolonged oral administration could protect the heart against the aconitine-induced arrhythmia in rats. Eighty male Wistar rats were divided into two series (n = 8 in each group). In the first series, all groups (except the control (Con) group) were given a single oral dose of oleuropein (20 mg/Kg) 1, 3, 24 and 48 h before the infusion of aconitine. In the second series, except the Con group, the other four groups were given oral oleuropein (20 mg/Kg/day) for 3, 7, 14 and 28 days, before the infusion of aconitine. Electrocardiogram was recorded to monitor arrhythmia. Data of the first series showed that the initiation time of arrhythmia, the initiation of ventricular tachycardia (VT), the numbers of reversible ventricular fibrillation (VF) and the death time had no significant difference compared with Con group. In the second series, a significant protection was occurred only in the 28 days group that was evident with increased initiation time of arrhythmia, increased initiation time of VT, and increased the number of reversible VF and death time in compared to the Con group. The findings of this study show that the oral administration of a single dose of oleuropein could not mimic the preconditioning effects in rat hearts, but the prolonged administration of oleuropein for about four weeks could protect the heart against aconitine-induced arrhythmia.